Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention

Oncology Reports

Volumn 8, Issue 2, 2001, Pages 373-379

  Rodríguez Burford, Cristina ^a  

^a Kentucky   (United States)

Author keywords

Body weight; Chemoprevention; Mammary cancer; Methylnitrosourea (MNU); Toremifene

Indexed keywords

ANTINEOPLASTIC AGENT; METHYLNITROSOUREA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TOREMIFENE;

ADENOCARCINOMA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME; WEIGHT GAIN;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TIME FACTORS; TOREMIFENE; WEIGHT GAIN;

EID: 0035292669     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.2.373     Document Type: Article

References (2)

1. Rodfguez-Burford C, Lubet RA, Eto I, Juliana MM, Kelloff GJ, Grubbs CJ and Steele VE: Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model. Carcinogenesis 20: 71-76, 1999.
2. Grubbs CJ, Eto I, Juliana MM, Hardin JM and Whitaker LM: Effects of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Anticancer Res 10: 661-666, 1990.